Table 1

SPECT and PET tracers: established and in development

IndicationSPECTPET
Myocardial blood flow
(currently available)
201Thallium
99mTc-sestamibi
99mTc–tetrofosmin
13N-NH3 (cyclotron)
15O-H2O (cyclotron)
82Rb
Myocardial blood flow (in development)123I-CMICE-013; 7′-(Z)-[123I] iodorotenone18F-flurpiridaz
Glucose metabolism18F-FDG (using 511 keV collimators)18F-FDG
Ventricular function99mTc–pertechnetate
Sympathetic innervation123I-meta-iodo-benzyl-guanidine (123I-mIBG)11C-hydroxyephedrine
11C-epinephrine (cyclotron)
Amyloidosis99mTc–DPD18F-florbetapir
Hydroxyapatite (research)18F-NaF
infection99mTc-labelled leucocytes18F-FDG; 68Ga
Inflammation (e.g., sarcoid)67Ga18F-FDG
Apoptosis99mTc-annexin V18F-annexin V; 68Ga-annexin V
Right to left shunt quantification99mTc-MAA
Fatty acidβ-methyl-p-[123I]iodo-phenyl-pentadecanoic acid (123I-BMIPP)18F-FTHA
TCA cycle11C-acetate (cyclotron)
Angiogenesis (integrin receptors)99mTc–RGD18F-fluciclatide; 18F-galacto-RGD
Macrophage activation18F-choline; 18F-folate; 18F-FDM; 11C-choline;11C-PK11195; 68Ga-DOTATATE
Hypoxia18F-MISO
MMP activation18F-RXP470
  • This is not a complete list which reflects the research activity, especially in PET tracers.

  • DPD, 3,3-diphosphono-1,2-propanodicarboxylic acid; FDG, fluorodeoxyglucose; MAA, macro-aggregated albumin; mIBG, metaiodobenzylguanidine; NaF, sodium fluoride; PET, positron emission tomography; SPECT, single photon emission computed tomography.